Condition (MeSH)
Blastomycosis
ClinicalTrials.gov lists 10 trials for Blastomycosis or a narrower condition beneath it. National Center for Research Resources (NCRR) has the most among industry and government lead sponsors, with 2.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
10 of the 10 trials are tagged with Blastomycosis itself; the rest are tagged with a narrower condition beneath it.
When did Blastomycosis trials start? (8)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Phase 2/3
- Phase 3
- Phase 4
- Observational
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2023 | 1 |
| 2018 | 1 |
| 2017 | 1 |
| 2015 | 1 |
| 2008 | 1 |
| 1998 | 1 |
| 1991 | 1 |
No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 10 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Blastomycosis trials in? (6)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1/2 | 1 |
| Phase 2 | 2 |
| Phase 2/3 | 1 |
| Phase 3 | 3 |
| Phase 4 | 1 |
| Observational | 2 |
How many Blastomycosis trials are recruiting? (3)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Completed | 8 |
| Terminated | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Blastomycosis trials? (6)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| National Center for Research Resources (NCRR) | 2 |
| Caja Costarricense de Seguro Social | 1 |
| Janssen Pharmaceutical K.K. | 1 |
| Janssen, LP | 1 |
| National Cancer Institute (NCI) | 1 |
Showing 5 of 6 sponsors.
Which drugs are being tested for Blastomycosis? (4)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Itraconazole | 2 |
| AMPHOTERICIN B | 2 |
| IBREXAFUNGERP | 1 |
| VT-1161 | 1 |
Interventions as named in the registry (6)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Voriconazole 1% | 1 |
| Fluconazol | 1 |
| Conventional itraconazole | 1 |
| SUBA itraconazole | 1 |
| ITCZ-IV | 1 |
Showing 5 of 6 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Blastomycosis trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Acute kidney injury | 7 | 1 |
| Diarrhoea | 6 | 1 |
| Pneumonia | 6 | 3 |
| Respiratory failure | 6 | 1 |
| COVID-19 | 5 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Blastomycosis? (5)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Successful treatment of pulmonary blastomycosis with continuously infused amphotericin B deoxycholate after failure with liposomal amphotericin B. | The Annals of pharmacotherapy | 2013 | Yes |
| Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2008 | Yes |
| Recurrent blastomycosis of the central nervous system: case report and review. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2000 | Yes |
| Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2016 | No |
| Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections. | Drugs | 1982 | No |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.